Literature DB >> 2160964

Regulation of the synthesis of platelet-activating factor and its inactive storage precursor (1-alkyl-2-acyl-sn-glycero-3-phosphocholine) from 1-alkyl-2-acetyl-sn-glycerol by rabbit platelets.

T C Lee1, B Malone, M L Blank, V Fitzgerald, F Snyder.   

Abstract

We have established previously that 1-alkyl-2-acetyl-sn-glycerol (alkylacetyl-G) can be converted into at least six metabolites by rabbit platelets, including alkylacetyl-sn-(glycero-3-phosphocholine) (-GPC), i.e. platelet-activating factor (PAF) and 1-alkyl-2-acyl-sn- (alkylacyl)-GPC. Since part of the biological functions of alkylacetyl-G can be explained by its metabolic conversion to PAF and also to alkylacyl-GPC as an inactive storage precursor of PAF, the present study focused on the regulation of the synthesis of PAF and alkylacyl-GPC from alkylacetyl-G. Our results document the presence of a specific dithiothreitol (DTT)-insensitive cholinephosphotransferase in saponin-permeabilized rabbit platelets and show that DTT potentiates the production of PAF from alkylacetyl-G but inhibits the formation of phosphatidylcholine from diolein. We also demonstrated that the availability of CDP-choline controls the generation of PAF from alkylacetyl-G. Furthermore, when CTP: phosphocholine cytidylyltransferase is activated to produce more CDP-choline through the translocation of this enzyme from the cytosol to membranes by incubating the rabbit platelets with 0.2 mM sodium oleate, the production of PAF from alkylacetyl-G is increased 5-fold. More importantly, our experiments reveal the presence of two metabolic pathways that are responsible for the synthesis of alkylacyl-GPC from alkylacetyl-G, with each producing a unique molecular species composition of the stored PAF precursor, alkylacyl-GPC. The latter is enriched in polyunsaturates (70.7-78.5% 20:4) when formed through the remodeling pathway of PAF cycle via alkylacetyl-G (DTT-insensitive cholinephosphotransferase)----alkylacetyl-GPC----alkyllyso-GPC---- alkylacyl-GPC . Alkylacyl-GPC containing saturated species (71.8% 16:0) is generated by the retroconversion/de novo pathway according to the reaction scheme of alkylacetyl-G----alkyl-G----alkyllyso-glycero-3-phosphate (-GP)----alkylacyl-GP----alkylacyl-G (DTT-sensitive cholinephosphotransferase)----alkylacyl-GPC. Inactivation of PAF through the remodeling/PAF cycle can generate alkylacyl-GPC at both low (1.75 x 10(-7) M) and high (10(-6) M) concentrations of PAF whereas the conversion of alkylacetyl-G to alkylacyl-GPC via PAF through the remodeling pathway only occurs at a low concentration (1.75 x 10(-7) M). At a high concentration (10(-6) M), alkylacetyl-G is converted to alkylacyl-GPC via the retroconversion/de novo route. These data suggest that the formation of PAF by the DTT-insensitive cholinephosphotransferase activity limits the amounts of alkylacyl-GPC produced from alkylacetyl-G through this remodeling pathway (PAF cycle).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160964

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation.

Authors:  Stephen P Holly; Jae Won Chang; Weiwei Li; Sherry Niessen; Ryan M Phillips; Raymond Piatt; Justin L Black; Matthew C Smith; Yacine Boulaftali; Andrew S Weyrich; Wolfgang Bergmeier; Benjamin F Cravatt; Leslie V Parise
Journal:  Chem Biol       Date:  2013-08-29

2.  Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis.

Authors:  Stephen P Holly; Nidhi Gera; Putianqi Wang; Alexander Wilson; Ziqiang Guan; Ling Lin; Brian Cooley; Hammodah R Alfar; Ruchi G Patil; Raymond Piatt; Tina M Leisner; Wolfgang Bergmeier; Rinku Majumder; Leslie V Parise
Journal:  Blood Adv       Date:  2019-11-26

Review 3.  Metabolic processing of PAF.

Authors:  F Snyder
Journal:  Clin Rev Allergy       Date:  1994

Review 4.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

5.  Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification.

Authors:  Daniel K Nomura; Kazutoshi Fujioka; Roger S Issa; Anna M Ward; Benjamin F Cravatt; John E Casida
Journal:  Toxicol Appl Pharmacol       Date:  2007-12-03       Impact factor: 4.219

Review 6.  Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling.

Authors:  Nikhil Rangholia; Tina M Leisner; Stephen P Holly
Journal:  Metabolites       Date:  2021-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.